Status:
COMPLETED
The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Staten Island University Hospital
Conditions:
Osteoporosis
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.
Eligibility Criteria
Inclusion
- Patients on warfarin that have had BMD within a year
Exclusion
- Patients on bisphosphates, SERMS, anticonvulsants, estrogens, androgens, calcitonin, hctz and thyroid hormone replacement
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00665613
Start Date
October 1 2004
End Date
March 1 2009
Last Update
October 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Staten Island University Hospital
Staten Island, New York, United States, 10305